Growth Metrics

Invivyd (IVVD) Capital Expenditures (2021 - 2025)

Invivyd posted quarterly Capital Expenditures of $11000.0 for Q2 2025, down 92.36% on a QoQ basis from $144000.0 in Q1 2025.

Invivyd (IVVD) has 5 years of Capital Expenditures data on file, last reported at $11000.0 in Q2 2025.

  • For the quarter ending Q2 2025, Capital Expenditures changed N/A year-over-year to $11000.0; the trailing twelve-month figure through Dec 2025 stood at $155000.0 (up 10.71% YoY), and the FY2025 full-year result was $155000.0, up 10.71% from the prior year.
  • Capital Expenditures for Q2 2025 stood at $11000.0, down from $144000.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $1.2 million in Q4 2022 and bottomed at -$9000.0 in Q2 2023.
  • The 5-year median for Capital Expenditures is $84000.0 (2021), against an average of $245363.6.
  • The widest annual swing landed in 2022, when Capital Expenditures surged 1341.67%; it then tumbled 152.94% in 2023.
  • A 5-year view of Capital Expenditures shows it stood at $84000.0 in 2021, then soared by 1341.67% to $1.2 million in 2022, then slumped by 100.74% to -$9000.0 in 2023, then soared by 44.44% to -$5000.0 in 2024, then jumped by 320.0% to $11000.0 in 2025.
  • The last three Capital Expenditures figures came in at $11000.0 (Q2 2025), $144000.0 (Q1 2025), and -$5000.0 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 133.40 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 230.60 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 21.83 Mn
10 Invivyd 208.38 Mn -18.31 Mn - -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2025 11,000.00
Jun 30, 2025 11,000.00
Mar 31, 2025 144,000.00
Mar 31, 2025 144,000.00
Dec 31, 2024 -5,000.00
Dec 31, 2024 -5,000.00
Sep 30, 2024 5,000.00
Sep 30, 2024 5,000.00
Mar 31, 2024 140,000.00
Mar 31, 2024 140,000.00
Jun 30, 2023 -9,000.00
Jun 30, 2023 -9,000.00
Mar 31, 2023 624,000.00
Mar 31, 2023 624,000.00
Dec 31, 2022 1.21 Mn
Dec 31, 2022 1.21 Mn
Sep 30, 2022 477,000.00
Sep 30, 2022 477,000.00
Jun 30, 2022 17,000.00
Jun 30, 2022 17,000.00
Dec 31, 2021 84,000.00
Dec 31, 2021 84,000.00